Atorvastatin Calcium Tablet
Product Images NDC 68180-635

8 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68180-635). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)

Image-01 (D800d38e 825d 41d4 B833 0e693d0851e0 01)
Chemical structure diagram of atorvastatin calcium, depicting the molecular arrangement including calcium ion (Ca2+) with three water molecules (3H2O). The structure shows the atorvastatin molecule with identifiable phenyl and fluorophenyl groups and functional groups relevant to the compound.*
FDA Label Image

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)

Figure 1: Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Non-fatalmyocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (D800d38e 825d 41d4 B833 0e693d0851e0 02)
A line chart comparing cumulative incidence percentages over approximately 3.5 years for Atorvastatin versus Placebo. The chart uses a solid line for Atorvastatin and a dashed line for Placebo, showing lower cumulative incidence with Atorvastatin across time. Hazard ratio (HR=0.64) and statistical significance (p=0.0005) are noted on the chart.*
FDA Label Image

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)

Figure 2: Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization, Or Stroke) (D800d38e 825d 41d4 B833 0e693d0851e0 03)
A cumulative hazard chart comparing Atorvastatin and placebo over four years of follow-up. The x-axis shows time to first primary endpoint in years, and the y-axis displays cumulative hazard percentage. The graph plots two lines, with Atorvastatin showing a lower cumulative hazard than placebo, indicating effectiveness over time.*
FDA Label Image

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)

Figure 3: Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (D800d38e 825d 41d4 B833 0e693d0851e0 04)
A line graph comparing Atorvastatin 10 mg and 80 mg showing the percentage of subjects experiencing a major cardiovascular event over a 5-year period. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects. The graph includes hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical analysis.*
FDA Label Image

05 (D800d38e 825d 41d4 B833 0e693d0851e0 05)

05 (D800d38e 825d 41d4 B833 0e693d0851e0 05)
Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets in a 30-count package from Lupin Pharmaceuticals, Inc. The label includes storage instructions and manufacturer information for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and Lupin Limited, Nagpur, India. The NDC code is 68180-635-06.*
FDA Label Image

06 (D800d38e 825d 41d4 B833 0e693d0851e0 06)

06 (D800d38e 825d 41d4 B833 0e693d0851e0 06)
Label for Atorvastatin Calcium Tablets, USP 20 mg oral tablets, containing 30 film-coated tablets. The label displays the strength prominently in a red box, includes storage instructions, prescribing information reference, and manufacturing details for Lupin Pharmaceuticals, Inc. and Lupin Limited (India). The label also states Rx only and includes a barcode.*
FDA Label Image

06 (D800d38e 825d 41d4 B833 0e693d0851e0 07)

06 (D800d38e 825d 41d4 B833 0e693d0851e0 07)
Atorvastatin Calcium Tablets, USP 40 mg film-coated tablet label by Lupin Pharmaceuticals, Inc. The label states 30 tablets per container, Rx only, with storage instructions and manufacturing details from Lupin Limited, India. The National Drug Code (NDC) is 68180-637-06.*
FDA Label Image

07 (D800d38e 825d 41d4 B833 0e693d0851e0 08)

07 (D800d38e 825d 41d4 B833 0e693d0851e0 08)
Atorvastatin Calcium Tablets, USP 80 mg film-coated oral tablets in a 30-tablet package. The label shows the NDC 68180-638-06, manufactured for Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and by Lupin Limited, India. Storage instructions and usual dosage information are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.